National Health Investors, Inc.
NHI · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $335 | $320 | $278 | $299 |
| % Growth | 4.8% | 15% | -6.9% | – |
| Cost of Goods Sold | $11 | $12 | $10 | $12 |
| Gross Profit | $324 | $308 | $268 | $287 |
| % Margin | 96.7% | 96.4% | 96.5% | 96.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $22 | $20 | $25 | $19 |
| SG&A Expenses | $22 | $20 | $25 | $19 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $118 | $110 | $110 | $82 |
| Operating Expenses | $140 | $130 | $136 | $102 |
| Operating Income | $184 | $179 | $133 | $185 |
| % Margin | 54.9% | 55.9% | 47.7% | 62% |
| Other Income/Exp. Net | -$47 | -$44 | -$67 | -$73 |
| Pre-Tax Income | $137 | $134 | $65 | $112 |
| Tax Expense | -$0 | $0 | -$0 | $0 |
| Net Income | $138 | $136 | $66 | $112 |
| % Margin | 41.2% | 42.4% | 23.9% | 37.4% |
| EPS | 3.14 | 3.13 | 0.52 | 1.36 |
| % Growth | 0.3% | 501.9% | -61.8% | – |
| EPS Diluted | 3.13 | 3.13 | 0.51 | 1.36 |
| Weighted Avg Shares Out | 44 | 43 | 45 | 46 |
| Weighted Avg Shares Out Dil | 44 | 43 | 45 | 46 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | -$3 | $0 | $0 |
| Interest Expense | $56 | $56 | $42 | $48 |
| Depreciation & Amortization | $71 | $70 | $71 | $81 |
| EBITDA | $264 | $260 | $179 | $241 |
| % Margin | 78.8% | 81.3% | 64.2% | 80.7% |